ID   MFN2_RAT                Reviewed;         757 AA.
AC   Q8R500; O09013;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   29-MAY-2024, entry version 132.
DE   RecName: Full=Mitofusin-2;
DE            EC=3.6.5.- {ECO:0000250|UniProtKB:O95140};
DE   AltName: Full=Mitochondrial transmembrane GTPase FZO1A;
DE            Short=Protein HSG;
DE   AltName: Full=Transmembrane GTPase MFN2;
GN   Name=Mfn2; Synonyms=Fzo1a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, MULTIMERIZATION, SUBUNIT, AND MUTAGENESIS OF LYS-109.
RC   TISSUE=Liver;
RX   PubMed=14561718; DOI=10.1093/jb/mvg150;
RA   Eura Y., Ishihara N., Yokota S., Mihara K.;
RT   "Two mitofusin proteins, mammalian homologues of FZO, with distinct
RT   functions are both required for mitochondrial fusion.";
RL   J. Biochem. 134:333-344(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=SHR, and Wistar Kyoto; TISSUE=Aorta;
RX   PubMed=15322553; DOI=10.1038/ncb1161;
RA   Chen K.-H., Guo X., Ma D., Guo Y., Li Q., Yang D., Li P., Qiu X., Wen S.,
RA   Xiao R.-P., Tang J.;
RT   "Dysregulation of HSG triggers vascular proliferative disorders.";
RL   Nat. Cell Biol. 6:872-883(2004).
RN   [3]
RP   FUNCTION.
RX   PubMed=12589796; DOI=10.1016/s0006-291x(03)00050-0;
RA   Ishihara N., Jofuku A., Eura Y., Mihara K.;
RT   "Regulation of mitochondrial morphology by membrane potential, and DRP1-
RT   dependent division and FZO1-dependent fusion reaction in mammalian cells.";
RL   Biochem. Biophys. Res. Commun. 301:891-898(2003).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=14592431; DOI=10.1016/j.bbrc.2003.10.008;
RA   Honda S., Hirose S.;
RT   "Stage-specific enhanced expression of mitochondrial fusion and fission
RT   factors during spermatogenesis in rat testis.";
RL   Biochem. Biophys. Res. Commun. 311:424-432(2003).
RN   [5]
RP   FUNCTION.
RX   PubMed=12598526; DOI=10.1074/jbc.m212754200;
RA   Bach D., Pich S., Soriano F.X., Vega N., Baumgartner B., Oriola J.,
RA   Daugaard J.R., Lloberas J., Camps M., Zierath J.R., Rabasa-Lhoret R.,
RA   Wallberg-Henriksson H., Laville M., Palacin M., Vidal H., Rivera F.,
RA   Brand M., Zorzano A.;
RT   "Mitofusin-2 determines mitochondrial network architecture and
RT   mitochondrial metabolism. A novel regulatory mechanism altered in
RT   obesity.";
RL   J. Biol. Chem. 278:17190-17197(2003).
RN   [6]
RP   INTERACTION WITH VAT1.
RX   PubMed=17105775; DOI=10.1242/jcs.03253;
RA   Eura Y., Ishihara N., Oka T., Mihara K.;
RT   "Identification of a novel protein that regulates mitochondrial fusion by
RT   modulating mitofusin (Mfn) protein function.";
RL   J. Cell Sci. 119:4913-4925(2006).
CC   -!- FUNCTION: Mitochondrial outer membrane GTPase that mediates
CC       mitochondrial clustering and fusion (PubMed:12589796, PubMed:12598526,
CC       PubMed:14561718, PubMed:15322553). Mitochondria are highly dynamic
CC       organelles, and their morphology is determined by the equilibrium
CC       between mitochondrial fusion and fission events. Overexpression induces
CC       the formation of mitochondrial networks. Membrane clustering requires
CC       GTPase activity and may involve a major rearrangement of the coiled
CC       coil domains (By similarity). Plays a central role in mitochondrial
CC       metabolism and may be associated with obesity and/or apoptosis
CC       processes (PubMed:12598526). Plays an important role in the regulation
CC       of vascular smooth muscle cell proliferation (PubMed:15322553).
CC       Involved in the clearance of damaged mitochondria via selective
CC       autophagy (mitophagy). Is required for PRKN recruitment to
CC       dysfunctional mitochondria (By similarity). Involved in the control of
CC       unfolded protein response (UPR) upon ER stress including activation of
CC       apoptosis and autophagy during ER stress (By similarity). Acts as an
CC       upstream regulator of EIF2AK3 and suppresses EIF2AK3 activation under
CC       basal conditions (By similarity). {ECO:0000250|UniProtKB:O95140,
CC       ECO:0000250|UniProtKB:Q80U63, ECO:0000269|PubMed:12589796,
CC       ECO:0000269|PubMed:12598526, ECO:0000269|PubMed:14561718,
CC       ECO:0000269|PubMed:15322553}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189;
CC         Evidence={ECO:0000250|UniProtKB:O95140};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670;
CC         Evidence={ECO:0000250|UniProtKB:O95140};
CC   -!- SUBUNIT: Forms homomultimers and heteromultimers with MFN1
CC       (PubMed:14561718). Oligomerization is essential for mitochondrion
CC       fusion (Probable). Interacts with VAT1 (PubMed:17105775). Interacts
CC       with STOML2; may form heterooligomers (By similarity). Interacts
CC       (phosphorylated) with PRKN (By similarity). Interacts with EIF2AK3 (By
CC       similarity). Interacts with THG1L; THG1L probably functions as a
CC       guanyl-nucleotide exchange factor/GEF, activating MFN2.
CC       {ECO:0000250|UniProtKB:O95140, ECO:0000250|UniProtKB:Q80U63,
CC       ECO:0000269|PubMed:14561718, ECO:0000269|PubMed:17105775, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:14561718, ECO:0000269|PubMed:15322553}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:14561718}. Note=Colocalizes with
CC       BAX during apoptosis. {ECO:0000250|UniProtKB:O95140}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. In brain, it is more expressed than
CC       MFN1, while it is expressed at a weaker level than MFN1 in heart and
CC       testis. Expressed at high level in elongating spermatids of
CC       seminiferous tubules. Expression is markedly down-regulated in highly
CC       proliferative vascular smooth muscle cells (VSMCs) from the genetic
CC       hypertensive animal model SHR, as well as in balloon-injured Wistar
CC       Kyoto arteries. {ECO:0000269|PubMed:14561718,
CC       ECO:0000269|PubMed:14592431, ECO:0000269|PubMed:15322553}.
CC   -!- DOMAIN: A helix bundle is formed by helices from the N-terminal and the
CC       C-terminal part of the protein. The GTPase domain cannot be expressed
CC       by itself, without the helix bundle. Rearrangement of the helix bundle
CC       and/or of the coiled coil domains may bring membranes from adjacent
CC       mitochondria into close contact, and thereby play a role in
CC       mitochondrial fusion. {ECO:0000250|UniProtKB:Q8IWA4}.
CC   -!- PTM: Phosphorylated by PINK1. {ECO:0000250|UniProtKB:O95140}.
CC   -!- PTM: Ubiquitinated by non-degradative ubiquitin by PRKN, promoting
CC       mitochondrial fusion; deubiquitination by USP30 inhibits mitochondrial
CC       fusion (By similarity). Ubiquitinated by HUWE1 when dietary stearate
CC       (C18:0) levels are low; ubiquitination inhibits mitochondrial fusion
CC       (By similarity). {ECO:0000250|UniProtKB:O95140}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. Dynamin/Fzo/YdjA family. Mitofusin subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU01055}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB084165; BAB90982.1; -; mRNA.
DR   EMBL; U41803; AAB87720.3; -; mRNA.
DR   AlphaFoldDB; Q8R500; -.
DR   SMR; Q8R500; -.
DR   STRING; 10116.ENSRNOP00000059463; -.
DR   iPTMnet; Q8R500; -.
DR   PhosphoSitePlus; Q8R500; -.
DR   jPOST; Q8R500; -.
DR   PaxDb; 10116-ENSRNOP00000052539; -.
DR   ABCD; Q8R500; 1 sequenced antibody.
DR   AGR; RGD:628843; -.
DR   RGD; 628843; Mfn2.
DR   eggNOG; KOG0448; Eukaryota.
DR   InParanoid; Q8R500; -.
DR   PhylomeDB; Q8R500; -.
DR   Reactome; R-RNO-5205685; PINK1-PRKN Mediated Mitophagy.
DR   Reactome; R-RNO-9013419; RHOT2 GTPase cycle.
DR   Reactome; R-RNO-983231; Factors involved in megakaryocyte development and platelet production.
DR   PRO; PR:Q8R500; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0005525; F:GTP binding; IMP:RGD.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0051020; F:GTPase binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0043394; F:proteoglycan binding; IPI:RGD.
DR   GO; GO:0031267; F:small GTPase binding; IDA:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0009060; P:aerobic respiration; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0001825; P:blastocyst formation; ISO:RGD.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; ISO:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0071479; P:cellular response to ionizing radiation; IEP:RGD.
DR   GO; GO:1905232; P:cellular response to L-glutamate; IEP:RGD.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; IEP:RGD.
DR   GO; GO:0071287; P:cellular response to manganese ion; IEP:RGD.
DR   GO; GO:0072705; P:cellular response to mercaptoethanol; IEP:RGD.
DR   GO; GO:0071394; P:cellular response to testosterone stimulus; IEP:RGD.
DR   GO; GO:0048312; P:intracellular distribution of mitochondria; IMP:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:0051560; P:mitochondrial calcium ion homeostasis; IMP:RGD.
DR   GO; GO:0008053; P:mitochondrial fusion; IMP:RGD.
DR   GO; GO:0007006; P:mitochondrial membrane organization; ISS:UniProtKB.
DR   GO; GO:0051646; P:mitochondrion localization; ISO:RGD.
DR   GO; GO:0007005; P:mitochondrion organization; IMP:RGD.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IMP:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0045792; P:negative regulation of cell size; IMP:RGD.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IMP:RGD.
DR   GO; GO:0090258; P:negative regulation of mitochondrial fission; IMP:RGD.
DR   GO; GO:0046580; P:negative regulation of Ras protein signal transduction; ISO:RGD.
DR   GO; GO:1903427; P:negative regulation of reactive oxygen species biosynthetic process; IMP:RGD.
DR   GO; GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IMP:RGD.
DR   GO; GO:0060299; P:negative regulation of sarcomere organization; IMP:RGD.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:UniProtKB.
DR   GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0061734; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; ISO:RGD.
DR   GO; GO:1901857; P:positive regulation of cellular respiration; IMP:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IMP:RGD.
DR   GO; GO:2000866; P:positive regulation of estradiol secretion; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0046326; P:positive regulation of glucose import; IMP:RGD.
DR   GO; GO:0010729; P:positive regulation of hydrogen peroxide biosynthetic process; IMP:RGD.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; IMP:RGD.
DR   GO; GO:0010918; P:positive regulation of mitochondrial membrane potential; IMP:RGD.
DR   GO; GO:2000386; P:positive regulation of ovarian follicle development; IMP:RGD.
DR   GO; GO:2000872; P:positive regulation of progesterone secretion; IMP:RGD.
DR   GO; GO:1903428; P:positive regulation of reactive oxygen species biosynthetic process; IMP:RGD.
DR   GO; GO:1905461; P:positive regulation of vascular associated smooth muscle cell apoptotic process; ISO:RGD.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0034497; P:protein localization to phagophore assembly site; ISO:RGD.
DR   GO; GO:0006626; P:protein targeting to mitochondrion; ISS:UniProtKB.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0046686; P:response to cadmium ion; IEP:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IEP:RGD.
DR   GO; GO:1905377; P:response to D-galactose; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0070542; P:response to fatty acid; IEP:RGD.
DR   GO; GO:1905395; P:response to flavonoid; IEP:RGD.
DR   GO; GO:1990910; P:response to hypobaric hypoxia; IEP:RGD.
DR   GO; GO:1903576; P:response to L-arginine; IEP:RGD.
DR   GO; GO:0014850; P:response to muscle activity; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0033574; P:response to testosterone; IEP:RGD.
DR   GO; GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   CDD; cd09912; DLP_2; 1.
DR   Gene3D; 1.20.5.110; -; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR045063; Dynamin_N.
DR   InterPro; IPR006884; Fzo/mitofusin_HR2.
DR   InterPro; IPR030381; G_DYNAMIN_dom.
DR   InterPro; IPR027094; Mitofusin_fam.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10465:SF1; MITOFUSIN-2; 1.
DR   PANTHER; PTHR10465; TRANSMEMBRANE GTPASE FZO1; 1.
DR   Pfam; PF00350; Dynamin_N; 1.
DR   Pfam; PF04799; Fzo_mitofusin; 1.
DR   SUPFAM; SSF111479; Fzo-like conserved region; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS51718; G_DYNAMIN_2; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Autophagy; Coiled coil; GTP-binding; Hydrolase; Membrane;
KW   Mitochondrion; Mitochondrion outer membrane; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Transmembrane; Transmembrane helix;
KW   Ubl conjugation; Unfolded protein response.
FT   CHAIN           1..757
FT                   /note="Mitofusin-2"
FT                   /id="PRO_0000127677"
FT   TOPO_DOM        1..604
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        605..625
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        626
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        627..647
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        648..757
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          93..342
FT                   /note="Dynamin-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          30..94
FT                   /note="Part of a helix bundle domain, formed by helices
FT                   from N-terminal and C-terminal regions"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   REGION          103..110
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          129..130
FT                   /note="G2 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          199..202
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          258..261
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          288
FT                   /note="G5 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          359..385
FT                   /note="Part of a helix bundle domain, formed by helices
FT                   from N-terminal and C-terminal regions"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   REGION          722..753
FT                   /note="Part of a helix bundle domain, formed by helices
FT                   from N-terminal and C-terminal regions"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   COILED          406..435
FT                   /evidence="ECO:0000255"
FT   COILED          696..738
FT                   /evidence="ECO:0000255"
FT   BINDING         106..111
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   BINDING         258..261
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   BINDING         305
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   BINDING         307
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   MOD_RES         111
FT                   /note="Phosphothreonine; by PINK1"
FT                   /evidence="ECO:0000250|UniProtKB:O95140"
FT   MOD_RES         442
FT                   /note="Phosphoserine; by PINK1"
FT                   /evidence="ECO:0000250|UniProtKB:O95140"
FT   MUTAGEN         109
FT                   /note="K->T: Induces mitochondria fragmentation when
FT                   overexpressed."
FT                   /evidence="ECO:0000269|PubMed:14561718"
FT   CONFLICT        183
FT                   /note="W -> L (in Ref. 2; AAB87720)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        194
FT                   /note="G -> D (in Ref. 2; AAB87720)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        265
FT                   /note="S -> P (in Ref. 2; AAB87720)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        404
FT                   /note="I -> M (in Ref. 2; AAB87720)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        431
FT                   /note="S -> T (in Ref. 2; AAB87720)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        756
FT                   /note="S -> G (in Ref. 2; AAB87720)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   757 AA;  86123 MW;  BE8340E0891A7DF4 CRC64;
     MSLLFSRCNS IVTVKKDKRH MAEVNASPLK HFVTAKKKIN GIFEQLGAYI QESAGFLEDT
     HRNTELDPVT TEEQVLDVKG YLSKVRGISE VLARRHMKVA FFGRTSNGKS TVINAMLWDK
     VLPSGIGHTT NCFLRVGGTD GHEAFLLTEG SEEKKSVKTV NQLAHALHQD EQLHAGSLVS
     VMWPNSKCPL LKDGLVLMDS PGIDVTTELD SWIDKFCLDA DVFVLVANSE STLMQTEKQF
     FHKVSERLSR PNIFILNNRW DASASEPEYM EEVRRQHMER CTSFLVDELG VVDRAQAGDR
     IFFVSAKEVL SARVQKAQGM PEGGGALAEG FQVRMFEFQN FERRFEECIS QSAVKTKFEQ
     HTVRAKQIAE AVRLIMDSLH IAAQEQRVYC LEMREERQDR LRFIDKQLEL LAQDYKLRIK
     QMTEEVERQV STAMAEEIRR LSVLVDEYQM DFHPSPVVLK VYKNELHRHI EEGLGRNMSD
     RCSTAIASSL QTMQQDMIDG LKPLLPVSVR NQIDMLVPRQ CFSLSYDLNC DKLCADFQED
     IEFHFSLGWT MLVNRFLGPK NSRRALLGYN DQVQRPLPLT PANPSMPPLP QGSLTQEELM
     VSMVTGLASL TSRTSMGILV VGGVVWKAVG WRLIALSFGL YGLLYVYERL TWTTRAKERA
     FKRQFVEYAS EKLQLIISYT GSNCSHQVQQ ELSGTFAHLC QQVDITRDNL EQEIAAMNKK
     VEALDSLQSK AKLLRNKAGW LDSELNMFIH QYLQPSR
//
